These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1444188)

  • 1. [Epidemiology and prevention of colorectal cancer].
    Faivre J; Pillon D; Michiels C
    Ann Gastroenterol Hepatol (Paris); 1992; 28(4):199-204. PubMed ID: 1444188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of colorectal cancer. Prospects of prevention].
    Faivre J
    Rev Prat; 1994 Dec; 44(20):2683-7. PubMed ID: 7878356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental and familial risk factors in relation to the colorectal adenoma--carcinoma sequence: results of a case-control study in Burgundy (France).
    Faivre J; Boutron MC; Senesse P; Couillault C; Belighiti C; Meny B
    Eur J Cancer Prev; 1997 Apr; 6(2):127-31. PubMed ID: 9237060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology and screening of colorectal cancer].
    Dancourt V; Faivre J
    Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
    Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
    Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for cancer control: colorectal cancer.
    Cox B; Sneyd M
    N Z Med J; 2005 Aug; 118(1221):U1632. PubMed ID: 16138170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
    Loss J; Eichhorn C; Nagel E
    Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas.
    Sinha R; Kulldorff M; Chow WH; Denobile J; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):559-62. PubMed ID: 11352869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass screening for colorectal cancer in Japan.
    Hisamichi S; Fukao A; Fujii Y; Tsuji I; Komatsu S; Inawashiro H; Tsubono Y
    Cancer Detect Prev; 1991; 15(5):351-6. PubMed ID: 1751945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
    Malila N; Oivanen T; Hakama M
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mass screening of colorectal cancer by general practitioners in France: what is the real target population?].
    Desoubeaux N; Herbert C; Launoy G; Vallée JP; Bouvier V; Maurel J; Née E; Gignoux M
    Gastroenterol Clin Biol; 1997; 21(10):760-3. PubMed ID: 9587517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
    Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
    J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it reasonable to use faecal occult blood test for colorectal cancer screening?
    Musil D; Tillich J
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():119-21. PubMed ID: 10743740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.